31 October 2018 (Wednesday) - Transfusion News email

Drugs to be used for cases of cold agglutinins, a new analyser on the market, more antigen matching… this instalment of “Transfusion News” is one of the more gripping ones…

Eculizumab for Treating Cold Agglutinin Disease
Transfusion News Image 1
October 24, 2018
Cold agglutinin disease (CAD) is a rare autoimmune disease caused by antibodies directed against red blood cell antigens, making them agglutinate at colder temperatures and activate complement. Current treatments for CAD are limited and include avoiding cold temperatures, inhibiting B-cell production of autoantibodies, and providing transfusions to combat hemolysis. Researchers in Germany [Read More]
Bio-Rad Receives U.S. FDA Clearance for the IH-Reader 24, Expanding the Company’s Offering for the Blood Typing Market
Transfusion News Image 1
A combination centrifuge and reader, the IH-Reader 24 automatically reads and transfers blood type and antibody screening results to Bio-Rad’s IH-Com patient data management software, offering improved efficiencies for transfusion medicine laboratories that use manual methods to test blood. [Click for More]
Antigen Matching for Future Moms with Meghan Delaney
Transfusion News Image 1
October 29, 2018 | BBGuy Podcast
A 25-year-old, A negative female needs blood. She will receive RhD-negative RBCs, of course, but what about antigen matching for Kell, or for other Rh antigens? Meghan Delaney explains the “AMIGO Study.” [Listen Now]
Listen on Apple PodcastGet It on Google Plan
Sexually Transmitted Disease Rates among Reinstated MSM Donors
Transfusion News Image 1
October 17, 2018
In December 2016, the American Red Cross began collecting blood from men who have sex with men (MSM) in line with the FDA’s newly changed deferral policy, which allows donations from MSM with no sexual activity with men in the prior 12 months. At the AABB Annual Meeting in Boston [Read More]

No comments:

Post a Comment